In patients with breast cancer, the Griffin framework proved to properly perform estrogen receptor (ER) subtyping from ULP-WGS of ctDNA and discriminate between ER-positive and ER-negative tumors76. The gene discussed is ESR1; the disease is breast carcinoma.